Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: South Korea Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20094
20101
20112
20121
20172
20192
20201
20212
20222
20232
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Pfizer4
Novo Nordisk A/S3
Amgen2
Bayer2
Hyundai Pharm2
AstraZeneca1
Bristol-Myers Squibb1
Chong Kun Dang Pharmaceutical1
Daewoong Pharmaceutical Co. LTD.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 228
Obesity3
Renal Insufficiency, Chronic3
Diabetic Nephropathies2
Heart Failure2
Albuminuria1
Diabetes Mellitus1
Hyperglycemia1
Hypertension1
Overweight1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.